Natural History of Patients with Multiple Myeloma Refractory to CD38-Targeted Monoclonal Antibody-Based Treatment
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Ujjawal H Gandhi, Arjun Lakshman, Zhubin Gahvari, Elizabeth McGehee, Megan Helena Jagosky, Ridhi Gupta, William Varnado, Saurabh Chhabra, Mark A. Fiala, Ehsan Malek, Joshua Mansour, Barry Paul, Alyssa Barnstead, Saranya Kodali, Amarendra K. Neppalli, Michaela Liedtke, Kelly N. Godby, Yubin Kang, Ankit Kansagra, Emma C. Scott, Elvira Umyarova, Parameswaran Hari, Ravi Vij, Saad Z. Usmani, Natalie Scott Callander, Robert Frank Cornell, Shaji K. Kumar, Luciano J Costa
Institutions: Vanderbilt University, Vanderbilt University Medical Center, Mayo Clinic, University of Wisconsin–Madison, The University of Texas Southwestern Medical Center, Levine Cancer Institute, Stanford Cancer Institute, Stanford University, University of Alabama at Birmingham, Medical College of Wisconsin, Washington University in St. Louis, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Medical University of South Carolina, Duke University, Duke Medical Center, Oregon Health & Science University, University of Vermont, MUSC Hollings Cancer Center, OHSU Knight Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2906871237